TY  - JOUR 
AU  - Laws, H.-J.
AU  - Fukutake, K.
AU  - López Fernández, María Fernanda
AU  - Li, Y.
AU  - Seifert, W.
AU  - Tagliaferri, A.
PY  - 2023
SN  - 1600-0609
UR  - http://hdl.handle.net/20.500.11940/21106
AB  - Objective: To assess the impact of prophylaxis with rIX-FP, a fusion protein linking recombinant factor IX (FIX) with human albumin, on joint outcomes. Methods: Joint outcomes were assessed in pediatric (<12 years) and adult/adolescent (?12 years)...
LA  - eng
KW  - Adult
KW  - Adolescent
KW  - Humans
KW  - Child
KW  - Factor IX
KW  - Hemophilia B
KW  - Recombinant Fusion Proteins
KW  - Hemostasis
KW  - Hemarthrosis
KW  - Hemophilia A
TI  - Assessment of joint bleeding and target joints in patients with severe or moderately severe hemophilia B (factor IX ?2%) receiving prophylaxis with rIX-FP in the PROLONG-9FP clinical trial program
DO  - 10.1111/ejh.14010
T2  - European Journal of Haematology
M2  - 293
KW  - AS A Coruña
KW  - CHUAC
VL  - 111
ER  -